NASDAQ:CRBP - Corbus Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$7.86 -0.14 (-1.75 %)
(As of 01/17/2019 01:49 AM ET)
Previous Close$8.00
Today's Range$7.81 - $8.16
52-Week Range$4.50 - $9.95
Volume550,900 shs
Average Volume1.44 million shs
Market Capitalization$455.04 million
P/E Ratio-12.09
Dividend YieldN/A
Beta2.11

Analyst Ratings

Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Corbus Pharmaceuticals in the last 12 months. Their average twelve-month price target is $26.20, suggesting that the stock has a possible upside of 233.33%. The high price target for CRBP is $38.00 and the low price target for CRBP is $22.00. There are currently 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.20$26.25$26.6667$25.3333
Price Target Upside: 233.33% upside294.14% upside255.56% upside325.77% upside

Corbus Pharmaceuticals (NASDAQ:CRBP) Consensus Price Target History

Price Target History for Corbus Pharmaceuticals (NASDAQ:CRBP)

Corbus Pharmaceuticals (NASDAQ:CRBP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/11/2019Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$36.00 ➝ $38.00HighView Rating Details
1/4/2019HC WainwrightReiterated RatingBuy$24.00MediumView Rating Details
12/7/2018Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$23.00HighView Rating Details
10/24/2018B. RileyInitiated CoverageBuy ➝ Buy$22.00HighView Rating Details
3/13/2018Noble FinancialReiterated RatingBuyMediumView Rating Details
1/19/2018Raymond JamesInitiated CoverageOutperform ➝ Outperform$24.00HighView Rating Details
4/3/2017JMP SecuritiesReiterated RatingOutperform$20.00 ➝ $27.00LowView Rating Details
(Data available from 1/17/2017 forward)
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel